get Started

Sodium

MCV (Mean Corpuscular Volume)

TIBC (Total Iron Binding Capacity)

Immature Granulocytes

Platelet Count

Copper Serum

Apolipoprotein B

RBC (Red Blood Cell Count)

IGF-1 (Insulin-Like Growth Factor 1)

LDL Particle Size

eGFR (Estimated Glomerular Filtration Rate)

BUN/Creatinine Ratio

Monocytes (Absolute)

Hematocrit

RBC Magnesium

Ferritin

Uric Acid

Tg Ab (Thyroglobulin Antibodies)

Glucose

Hemoglobin A1C

Alkaline Phosphatase (ALP)

TPO Ab (Thyroid Peroxidase Antibodies)

Serum Cortisol

Bicarbonate

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

Vitamin A (Retinol)

Bilirubin (Total and Direct)

Hemoglobin

SHBG (Sex Hormone Binding Globulin)

Lymphocytes (Absolute)

Total Protein

25(OH)D (25-Hydroxyvitamin D)

NRBC (Nucleated Red Blood Cells)

TSH (Thyroid Stimulating Hormone)

Cystatin C

MCHC (Mean Corpuscular Hemoglobin Concentration)

Albumin

Total Testosterone

GGT (Gamma-Glutamyl Transferase)

Free T3 (Triiodothyronine)
Apolipoprotein B is a biomarker that can be used to assess cardiovascular disease risk and potential longevity. Understanding and monitoring this marker is crucial for maintaining overall health and longevity.

Apolipoprotein B

Apolipoprotein B is a key biomarker used in assessing longevity. This protein plays a crucial role in lipid metabolism and is a significant risk factor for cardiovascular diseases, which are closely linked to longevity. Elevated levels of apolipoprotein B are associated with a higher risk of atherosclerosis and heart disease, while lower levels are indicative of better cardiovascular health and potential for longevity. Therefore, monitoring apolipoprotein B levels is essential in predicting and potentially improving an individual’s lifespan. By understanding and managing this biomarker, individuals can take proactive steps towards maintaining their cardiovascular health and promoting longevity.

Biomarker Explained

Apolipoprotein B is a crucial biomarker for assessing longevity due to its significant role in lipid metabolism and its strong association with cardiovascular diseases. Elevated levels of apolipoprotein B indicate a higher risk of atherosclerosis and heart disease, which can decrease one’s potential for longevity. On the other hand, lower levels of this biomarker are indicative of better cardiovascular health and a higher likelihood for a longer lifespan. Monitoring apolipoprotein B levels is essential in predicting an individual’s potential for longevity and in taking proactive steps towards maintaining cardiovascular health. By understanding and managing this biomarker, individuals can potentially improve their lifespan and overall well-being. Therefore, it is important for individuals to stay informed about their apolipoprotein B levels and work with healthcare professionals to ensure optimal cardiovascular health and potential for longevity.

Keywords:

Apolipoprotein B, longevity, biomarker, lipid metabolism, cardiovascular diseases, atherosclerosis, healthcare professionals

Your Longevity Clinic,
from Home.

Longevity Direct is an app within Longr’s Longevity OS, a platform dedicated to extending access to longevity. 

Verify Approval for www.longevity.direct

Home

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Science
About

Contact

Client portal

© 2025 Longr Holdings Inc.
1007 North Orange Street | DE 19801 | U.S.A

Prescription products require an online consultation with a physician who will determine if a prescription is appropriate. See product page for important safety information. Benefits outlined on Longevity Direct are based on 3rd party studies.

Note: The above statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. If you are in need of emergency medical attention, please call 911 immediately.

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

get Started
Client portal

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

FAQS
Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.